Area of research
Public Health, Environmental and Occupational Health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Prenatal Substance Exposure Effects, Maternal Mental Health During Pregnancy and Postpartum, Opioid Use Disorder Treatment, and Substance Abuse Treatment and Outcomes.
Reasons pregnant people use cannabis to self‐treat health conditions during pregnancy: Results from a <scp>US</scp> population‐based survey
Association of Race With Urine Toxicology Testing Among Pregnant Patients During Labor and Delivery
Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder
Disparities in Maternal-Infant Drug Testing, Social Work Assessment, and Custody at 5 Hospitals
Addressing stigma within the dissemination of research products to improve quality of care for pregnant and parenting people affected by substance use disorder
Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective
“You have to take this medication, but then you get punished for taking it:” lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period
Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort
Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder
Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate
Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts
Consensus guidelines and state policies: the gap between principle and practice at the intersection of substance use and pregnancy
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
Early lessons from maternal mortality review committees on drug-related deaths—time for obstetrical providers to take the lead in addressing addiction
The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection
Cognitive and Behavioral Impact on Children Exposed to Opioids During Pregnancy
Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery
Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
The role of screening, brief intervention, and referral to treatment in the perinatal period
Knowledge, Attitudes, and Practice of Electronic Cigarette Use Among Pregnant Women
P06.06 Azythromycin treatment for<i>chlamydia trachomatis</i>is associated with vaginal microbiota lacking protective<i>lactobacillus</i>spp
O05.4 Association Between Chlamydia Trachomatis Genital Infection and the Vaginal Microbiome
A missed opportunity for care: two-visit IUD insertion protocols inhibit placement
Placenta accreta: depth of invasion and neonatal outcomes